Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Am J Transplant. 2016 May 17;16(10):2903–2911. doi: 10.1111/ajt.13820

Figure 3 (two panels).

Figure 3 (two panels)

Figure 3 (two panels)

  1. a: Among-state measures of waitlist- and population-level mortality in HealthCore patients with ESLD*
    1. Footnote: * Data reported for the 16 states with ≥100 HealthCore patients with end-stage liver disease. The main plot demonstrates the correlation between waitlist- and population-level mortality rates, while the box-and-whisker plots demonstrate the absolute range in waitlist-and population-level mortality rates among the 16 sampled states.
  2. b: Among-state measures of waitlist- and population-level transplant rates in HealthCore patients with ESLD*
    1. Footnote: * Data reported for the 16 states with ≥100 HealthCore patients with end-stage liver disease. The main plot demonstrates the correlation between waitlist- and population-level transplant rates, while the box-and-whisker plots demonstrate the absolute range in waitlist-and population-level transplant rates among the 16 sampled states.